Related Experiment Video
Updated: Mar 2, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications
Bandar Al Ghamdi1, Walid Hassan1
1King Faisal Specialist Hospital and research centre, Riyadh, Saudi Arabia.
Insights
Atrial fibrillation (AF), a common heart rhythm disorder, is linked to stroke and mortality. Understanding atrial remodeling (AR) is key to developing effective treatments for AF.
Area of Science:
- Cardiology
- Electrophysiology
- Pathophysiology
Background:
- Atrial fibrillation (AF) is the most prevalent clinical arrhythmia, increasing with age.
- High-risk patients face significant thromboembolic stroke risk and mortality.
- The precise mechanisms of AF genesis remain incompletely understood, with evolving theories beyond re-entrant circuits.
Purpose of the Study:
- To review the mechanisms of atrial remodeling (AR).
- To discuss structural, electrophysiologic, and neurohormonal changes in AR.
- To explore AR's role in AF initiation and maintenance, including inflammation and therapeutic interventions.
Main Methods:
- Review of existing animal and human studies on atrial remodeling (AR) and AF.
- Analysis of structural, electrophysiological, and neurohormonal changes associated with AR.
- Discussion of the role of inflammation in AR and AF.
Main Results:
- AF triggers complex interactions leading to abnormal atrial substrates and remodeling.
- Atrial remodeling (AR) involves structural and electrical changes that promote AF maintenance.
- Inflammation plays a role in AR and AF initiation/maintenance.
Conclusions:
- Understanding AR mechanisms is crucial for effective AF ablation strategies.
- AR is central to both the development and persistence of atrial fibrillation.
- Targeting AR may offer therapeutic avenues to prevent AF.
Abstract:
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. The prevalence of AF increases dramatically with age and is seen in as high as 9% of individuals by the age of 80 years. In high-risk patients, the thromboembolic stroke risk can be as high as 9% per year and is associated with a 2-fold increase in mortality. Although the pathophysiological mechanism underlying the genesis of AF has been the focus of many studies, it remains only partially understood. Conventional theories focused on the presence of multiple re-entrant circuits originating in the atria that are asynchronous and conducted at various velocities through tissues with various refractory periods. Recently, rapidly firing atrial activity in the muscular sleeves at the pulmonary veins ostia or inside the pulmonary veins have been described as potential mechanism,. AF results from a complex interaction between various initiating triggers and development of abnormal atrial tissue substrate. The development of AF leads to structural and electrical changes in the atria, a process known as remodeling. To have effective surgical or catheter ablation of AF good understanding of the possible mechanism(s) is crucial.Once initiated, AF alters atrial electrical and structural properties that promote its maintenance and recurrence. The role of atrial remodeling (AR) in the development and maintenance of AF has been the subject of many animal and human studies over the past 10-15 years. This review will discuss the mechanisms of AR, the structural, electrophysiologic, and neurohormonal changes associated with AR and it is role in initiating and maintaining AF. We will also discuss briefly the role of inflammation in AR and AF initiation and maintenance, as well as, the possible therapeutic interventions to prevent AR, and hence AF, based on the current understanding of the interaction between AF and AR.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Aortic Regurgitation III: Medical Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Mitral Valve Prolapse I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

